Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-a1) is a critical component of the inhibitory nervous system in the primary mosquito vector of malaria [1, 4]. As a member of the Cys-loop ligand-gated ion channel superfamily, it is found exclusively in invertebrates, making it a highly selective target for insecticidal agents [3, 5]. AgGluCl-a1 functions as a chloride-selective channel that is activated by the neurotransmitter glutamate, leading to membrane hyperpolarization and the suppression of neuronal activity [2, 4]. It is the primary molecular target of the avermectin class of drugs, such as ivermectin, which acts as a potent allosteric agonist [1, 10]. Binding of ivermectin to the transmembrane domain of AgGluCl-a1 causes persistent channel opening, resulting in flaccid paralysis and death of the mosquito [1, 4]. This target is central to innovative malaria control strategies, including mass drug administration of ivermectin to human populations to reduce the lifespan and transmission potential of biting mosquitoes [4, 5]. Resistance to insecticides targeting AgGluCl-a1 can occur through alternative splicing or specific mutations in the channel subunits, which alter drug sensitivity without compromising physiological function [3, 19].
Allosteric agonist (avermectins) or antagonist (fipronil) of the glutamate-gated chloride channel, leading to hyperpolarization and paralysis of the insect nervous system.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anopheles gambiae glutamate-gated chloride channel alpha 1 subunit (AgGluCl-a1) (AgGluCl-a1).